B lymphocyte chemoattractant (BLC), also known as CXC motif ligand 13 (CXCL13), and its corresponding receptor CXCR5 have been reported to be part of SLE pathogenesis and the levels of BLC were higher in SLE patients than in healthy controls [41]. Here, CXCL13 is linked to systemic lupus erythematosus.